PDCD1LG2 and gastric cancer: According to published data, PD-L2 was confirmed highly expressed in HNSCC, salivary gland cancer (SGC), prostate cancer, gastric cancer, colorectal cancer, oesophageal adenocarcinoma, and bladder cancer.